Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company, which is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products through its contract manufacturing business and through licensing its development-stage immunotherapy products. Avid provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Type
Public
HQ
Tustin, US
Founded
1981
Size (employees)
319 (est)
Avid Bioservices was founded in 1981 and is headquartered in Tustin, US
Report incorrect company information

Key People/Management at Avid Bioservices

Roger Lias

Roger Lias

President and Chief Executive Officer
Paul Lytle

Paul Lytle

CFO
Show more

Avid Bioservices Office Locations

Avid Bioservices has an office in Tustin
Tustin, US (HQ)
14282 Franklin Ave
Show all (1)
Report incorrect company information

Avid Bioservices Financials and Metrics

Avid Bioservices Revenue

Avid Bioservices's revenue was reported to be $44.69 m in FY, 2016 which is a 66.9% increase from the previous period.
USD

Revenue (Q3, 2018)

46.7 m

Gross profit (Q3, 2018)

(963 k)

Gross profit margin (Q3, 2018), %

(2.1%)

Net income (Q3, 2018)

(24.8 m)

EBIT (Q3, 2018)

(14.5 m)

Market capitalization (22-Dec-2017)

179 m

Cash (31-Jan-2018)

17.9 m
Avid Bioservices's current market capitalization is $179 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

22.4 m26.8 m44.7 m

Revenue growth, %

20%67%

General and administrative expense

18.6 m

R&D expense

59.5 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

7.4 m3.9 m5.5 m6.3 m5.7 m9.7 m9.5 m6.7 m5.6 m23.4 m10.7 m12.8 m46.7 m

Cost of goods sold

16.2 m47.6 m

Gross profit

(3.5 m)(963 k)

Gross profit Margin, %

(27%)(2%)
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

77.5 m68 m61.4 m

Inventories

5.5 m7.4 m16.2 m33.1 m

Current Assets

85.8 m80.5 m81.8 m

PP&E

2.4 m15.1 m24.3 m
Quarterly
USDQ2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

44.4 m63.2 m55.2 m59 m72 m67.5 m44.2 m49.1 m41.5 m37.3 m27.7 m17.9 m

Inventories

4 m5.2 m6.1 m10.5 m12.6 m15.2 m25.3 m25.9 m33.8 m24.2 m16.5 m14.2 m

Current Assets

51.3 m72.2 m68.6 m72.3 m89.5 m93.6 m78.2 m82.8 m83 m70.8 m49 m41 m

PP&E

2.3 m2.5 m9 m18.4 m21.8 m23.8 m24.3 m24 m24.1 m24.4 m27.1 m26.3 m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(35.4 m)(50.4 m)(55.7 m)(28.2 m)

Depreciation and Amortization

986 k1 m1.5 m2.5 m

Inventories

(1.2 m)(1.8 m)(8.8 m)(16.9 m)

Accounts Payable

(391 k)3.3 m(3.5 m)(3.3 m)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Net Income

(7.8 m)(9.7 m)(13.1 m)(25.2 m)(13 m)(13.7 m)(13.2 m)(16.8 m)(11.1 m)(4.1 m)(7.8 m)(24.8 m)

Depreciation and Amortization

277 k542 k1.9 m

Inventories

(468 k)151 k6.1 m10.5 m12.6 m15.2 m25.3 m25.9 m33.8 m18.9 m

Accounts Payable

2.5 m484 k6.8 m9.8 m6.9 m7.8 m9.1 m11.6 m7.7 m(3.9 m)
USDY, 2018

Revenue/Employee

146.3 k

Financial Leverage

2.2 x
Show all financial metrics

Avid Bioservices Operating Metrics

FY, 2016

Phase 1/2 Trials Products

1
Show all operating metrics

Avid Bioservices Revenue Breakdown

Embed Graph

Avid Bioservices revenue breakdown by business segment: 99.3% from Contract manufacturing services and 0.7% from Other

Report incorrect company information

Avid Bioservices News and Updates

Report incorrect company information

Avid Bioservices Company Life and Culture

Report incorrect company information